Solifenacin Succinate
Who holds supplier records for Solifenacin Succinate? 34 organisations hold a current record for Solifenacin Succinate: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 27 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (19), China (3), Canada (1), Netherlands (1) and 6 other countries (6); not recorded for 4.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Solifenacin Succinate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/solifenacin-succinate
Reading the evidence
- 34 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
19 of the 30 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 16 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (34)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Solifenacin Succinate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 25887 · latest filing Apr 2012
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 22418 · latest filing Jan 2009
- AMOLI ORGANICS PRIVATE LTDIndiaCEPActive DMF 31789 · latest filing Aug 2017
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 27550 · latest filing Sept 2013
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 29489 · latest filing Nov 2015
- DELMAR CHEMICALS INCCanadaCEPActive DMF 30671 · latest filing Jul 2016
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 24871 · latest filing Apr 2011
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 24765 · latest filing Mar 2011
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 31459 · latest filing Mar 2017
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 23747 · latest filing Apr 2010
- OPTIMUS DRUGS PRIVATE LTDIndiaCEPActive DMF 30965 · latest filing Dec 2016
- Qilu Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 29503 · latest filing Jun 2015
- RUYUAN HEC PHARM CO LTDCEPActive DMF 35140 · latest filing Aug 2020
- SMS Pharmaceuticals limitedIndiaCEP Company GMP cert on recordActive DMF 36133 · latest filing Jul 2022
- TAPI NL BVNetherlandsCEPActive DMF 22173 · latest filing Nov 2008
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 30383 · latest filing Mar 2016
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)SpainCEPActive DMF 29581 · latest filing Jul 2015
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 22263 · latest filing Dec 2008
- INTERQUIM SAPeruCEP Company GMP cert on recordActive DMF 24154 · latest filing Sept 2010
- ISOCHEM SAFranceActive DMF 28870 · latest filing Nov 2014
- MEGAFINE PHARMA P LTDIndiaActive DMF 24186 · latest filing Sept 2010
- NOVUGEN PHARMA MALAYSIA SDN BHDActive DMF 33306 · latest filing Feb 2019
- RAKS PHARMA PVT LTDIndiaActive DMF 30541 · latest filing Jun 2016
- UNIMARK REMEDIES LTDIndiaActive DMF 23965 · latest filing Jul 2010
- WEIHAI DISU PHARMACEUTICAL CO LTDChinaActive DMF 28373 · latest filing Jan 2015
- DIJIA PHARMACEUTICAL GROUP CO LTDCEP
- MaltaCEP Company GMP cert on record
- IndiaCEP
- IndiaCEP
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordInactive DMF 24447 · latest filing Dec 2010
- TYCHE INDUSTRIES LTDCEP Company GMP cert on record
- JapanCEP Company GMP cert on record
- ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- DONGBANG FUTURE TECH & LIFE CO., LTD.South KoreaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (27)
Certificates of Suitability on the EDQM register for Solifenacin Succinate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 37 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shaoxing | CN | CEP 2021-166 - Rev 03 Solifenacin succinate | Nov 2026 | Inspected Mar 2025 Germany |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2026-383 - Rev 00 Solifenacin succinate, Process-II | Oct 2026 | — |
| MEGAFINE PHARMA PRIVATE LIMITED Mumbai | IN | CEP 2016-149 - Rev 01 Solifenacin succinate | Jul 2026 | — |
| RUYUAN HEC PHARM CO., LTD. Shaoguan | CN | CEP 2020-263 - Rev 01 Solifenacin succinate, Form-I | Jul 2026 | — |
| OPTIMUS DRUGS PRIVATE LIMITED Hyderabad | IN | CEP 2024-372 - Rev 01 Solifenacin succinate, Process-II | May 2026 | — |
| DONGBANG FUTURE TECH & LIFE CO., LTD. Hwaseong-Si | KR | CEP 2021-418 - Rev 01 Solifenacin succinate | Mar 2026 | — |
| SAPTAGIR LABORATORIES PRIVATE LIMITED Hyderabad | IN | CEP 2023-384 - Rev 00 Solifenacin succinate | Jan 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2025-401 - Rev 00 Solifenacin succinate, Process II, form-I, micronised and non-micronised | Nov 2025 | — |
| JUBILANT BIOSYS LIMITED Nanjangud | IN | CEP 2016-080 - Rev 02 Solifenacin succinate | Oct 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2024-429 - Rev 02 Solifenacin succinate, Process 2 | Oct 2025 | — |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2021-510 - Rev 02 Solifenacin succinate, Process-II | Sept 2025 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2016-059 - Rev 02 Solifenacin succinate | Jun 2025 | — |
| DIJIA PHARMACEUTICAL GROUP CO., LTD. Weihai | CN | CEP 2024-479 - Rev 00 Solifenacin succinate | May 2025 | — |
| SMS PHARMACEUTICALS LIMITED Hyderabad | IN | CEP 2023-388 - Rev 00 Solifenacin succinate | Apr 2025 | — |
| Yuki Gosei Kogyo Co., Ltd. Tokyo | JP | CEP 2023-361 - Rev 00 Solifenacin succinate | Jan 2025 | — |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | CEP 2024-431 - Rev 00 Solifenacin succinate, Process-II | Dec 2024 | — |
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2017-083 - Rev 01 Solifenacin succinate | Nov 2024 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2018-051 - Rev 01 Solifenacin succinate | Aug 2024 | — |
| QILU PHARMACEUTICAL CO., LTD. Jinan | CN | CEP 2022-122 - Rev 01 Solifenacin succinate | Jun 2024 | Inspected Feb 2025 Switzerland |
| Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona | ES | CEP 2017-094 - Rev 01 Solifenacin succinate | Apr 2024 | — |
| DELMAR CHEMICALS INC. LaSalle | CA | R1-CEP 2016-302 - Rev 00 Solifenacin succinate | Aug 2023 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2017-062 - Rev 00 Solifenacin succinate | Aug 2023 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | R1-CEP 2016-293 - Rev 00 Solifenacin succinate | Dec 2022 | — |
| MSN LABORATORIES PRIVATE LIMITED Rudraram Village | IN | R1-CEP 2016-201 - Rev 00 Solifenacin succinate | Aug 2022 | — |
| Interquim, S.A. Sant Cugat Del Vallès | ES | R1-CEP 2016-143 - Rev 00 Solifenacin succinate | Jul 2022 | — |
| MEDICHEM MANUFACTURING (MALTA) LTD. Hal Far | MT | R1-CEP 2016-240 - Rev 00 Solifenacin succinate | Apr 2022 | — |
| TYCHE INDUSTRIES LIMITED Hyderabad | IN | R0-CEP 2020-011 - Rev 00 Solifenacin succinate | Feb 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Solifenacin Succinate are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- Kyongbo Pharmaceutical Co., Ltd.South · Inactive DMF 28977 · filed Jan 2015
- Italy · Inactive DMF 26190 · filed Jun 2012
- CRYSTAL PHARMA LTDInactive DMF 26125 · filed Jun 2012
- PHF SAInactive DMF 25488 · filed Dec 2011
- Poland · Inactive DMF 24044 · filed Aug 2010
- India · Inactive DMF 23689 · filed Apr 2010
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Solifenacin Succinate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200803).
Chemical identity
- IUPAC name
- [(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate;butanedioic acid
- Canonical SMILES
- C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5.C(CC(=O)O)C(=O)O
- InChIKey
- RXZMMZZRUPYENV-VROPFNGYSA-N
- Synonyms
- Solifenacin succinate, Vesicare, Vesicare ls, YM-67905, YM67905, YM-905, YM905, YM 905, solifenacin succiate, solifenacine succinate, Succinate, Solifenacin, RefChem:6251
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cholinergic Muscarinic Antagonist
- Mechanism of action
- Cholinergic Muscarinic Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Solifenacin Succinate?
34 organisations hold an active US FDA Type II Drug Master File or a CEP for Solifenacin Succinate: Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), AMOLI ORGANICS PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India), DELMAR CHEMICALS INC (Canada), Hetero Drugs Limited (India) and JUBILANT BIOSYS LTD (India), and 26 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Solifenacin Succinate Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 25887), ALIVUS LIFE SCIENCES LTD (DMF 22418), AMOLI ORGANICS PRIVATE LTD (DMF 31789), APITORIA PHARMA PRIVATE LTD (DMF 27550), Cipla Limited (DMF 29489), DELMAR CHEMICALS INC (DMF 30671), Hetero Drugs Limited (DMF 24871) and JUBILANT BIOSYS LTD (DMF 24765) and 17 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Solifenacin Succinate records mean?
6 organisations have only inactive Type II DMFs for Solifenacin Succinate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Solifenacin Succinate have a European Certificate of Suitability?
Yes. 27 organisations hold a valid CEP for Solifenacin Succinate on the EDQM register, including ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shaoxing (CN), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), MEGAFINE PHARMA PRIVATE LIMITED Mumbai (IN), RUYUAN HEC PHARM CO., LTD. Shaoguan (CN), OPTIMUS DRUGS PRIVATE LIMITED Hyderabad (IN) and DONGBANG FUTURE TECH & LIFE CO., LTD. Hwaseong-Si (KR) and 21 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Solifenacin Succinate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Solifenacin Succinate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.